This guideline covers cardiac rehabilitation and preventing further cardiovascular disease in people aged 18 and over who have had a myocardial infarction. It aims to promote the health of people who have had an MI by encouraging them to attend a cardiac rehabilitation programme and advising them on a healthy lifestyle. It also includes advice on drug therapy.
Everything NICE has said on cardiac rehabilitation and preventing cardiovascular disease after myocardial infarction in an interactive flowchart
In development [GID-NG10085] Expected publication date: 30 July 2020
Evidence-based recommendations on rivaroxaban (Xarelto) for preventing atherothrombotic events in adults with coronary or peripheral artery disease
This guideline covers treatments for people aged 18 and over with unstable angina (recurring chest pain) or a type of heart attack called non-ST-segment-elevation myocardial infarction (NSTEMI). It aims to ensure that people get treatment quickly. It recommends that as soon as NSTEMI or unstable angina is diagnosed, healthcare professionals assess people for risk of more serious heart problems in the future to guide their treatment.
This quality standard covers preventing further cardiovascular disease after a myocardial infarction (heart attack). It includes assessment and cardiac rehabilitation. It describes high-quality care in priority areas for improvement.
place in treatment, specifically in a small minority of people with heart failure. Review and, if appropriate, revise prescribing
This quality standard covers promoting health and preventing premature mortality among black, Asian and other minority ethnic groups. It is relevant to all age groups and all settings.
This guideline covers managing stable angina in people aged 18 and over. It outlines the importance of addressing the person’s concerns about stable angina and the roles of medical therapy and revascularisation.
This quality standard covers diagnosing and managing acute coronary syndromes in adults (aged 18 and over). Acute coronary syndromes are medical emergencies that include myocardial infarction (heart attack) and unstable angina (unexpected, severe chest pain). It describes high-quality care in priority areas for improvement.
characteristics are associated with uptake and adherence to cardiac rehabilitation after an acute MI when...
Everything NICE has said on assessing and managing recent suspected cardiac chest pain including acute coronary syndromes and stable angina in an interactive flowchart
Evidence-based recommendations on rivaroxaban (Xarelto) for preventing adverse outcomes after acute management of acute coronary syndrome (ACS)
Evidence-based recommendations on MiraQ for assessing graft flow during coronary artery bypass graft surgery
Everything NICE has said on community engagement in an interactive flowchart
composite cardiovascular outcome (death from cardiovascular causes, myocardial infarction [MI], stroke, hospitalisation for...
Evidence-based recommendations on endoscopic saphenous vein harvest for coronary artery bypass grafting in coronary artery disease (CAD)
Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease (NICE
This quality standard covers assessing, diagnosing and managing chronic heart failure in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
This guideline covers the link between body mass index (BMI) and waist circumference and the risk of disease among adults from black, Asian and other minority ethnic groups in the UK. The aim was to determine whether lower cut-off points should be used for these groups as a trigger for lifestyle interventions to prevent conditions such as diabetes, myocardial infarction or stroke.
Evidence-based recommendations on high-sensitivity troponin tests for the early rule-out of acute myocardial infarction (AMI)
Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart
This quality standard covers the care of adults (aged 18 and over) with suspected or confirmed acute heart failure. It describes high-quality care in priority areas for improvement.
Question Does continuing beta-blocker treatment beyond 1 year after an MI improve outcomes for people with normal left ventricular...
Question In people who have not undergone revascularisation after an MI, does clopidogrel and placebo have a better outcome than...
treatment with an oral anticoagulant and clopidogrel in people who have had an MI, have an indication for oral anticoagulation and are...
benefit might occur in the short-term reduction of fatal and non-fatal re-infarction, and a reduced risk of stent thrombosis in patients...
Everything NICE has said on changing people's health-related behaviours, including interventions aimed at over 16s, in an interactive flowchart
Evidence-based recommendations on SeQuent Please balloon catheter for in-stent coronary restenosis
Everything NICE has said on recognising and managing psychosis and schizophrenia in children, young people and adults in an interactive flowchart
Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart
Evidence-based recommendations on alirocumab (Praluent) for treating primary hypercholesterolaemia (high cholesterol) and mixed dyslipidaemia
Everything NICE has said on identifying and managing common mental health disorders in adults in primary care in an interactive flowchart
Everything NICE has said on preventing type 2 diabetes in an interactive flowchart
Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart
Dementia assessment referral to GP (DeAR-GP) Re-engineering the Post-Myocardial Infarction Medicines Optimisation Pathway Young adult...
This guideline covers exercise referral schemes for people aged 19 and older, in particular, those who are inactive or sedentary. The aim is to encourage people to be physically active.
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.
This quality standard covers identifying and assessing cardiovascular risk in adults (aged 18 and over) and treatment to prevent cardiovascular disease. It describes high-quality care in priority areas for improvement.
This guideline covers interventions in the acute stage of a stroke or transient ischaemic attack (TIA). It offers the best clinical advice on the diagnosis and acute management of stroke and TIA in the 48 hours after onset of symptoms.
This guideline covers preventing, detecting, and managing acute kidney injury in children (aged above 1 month and below 12 years), young people (aged 12 to 17 years) and adults (aged 18 years or older). It aims to improve assessment and detection by non-specialist clinicians, and specifies when they should refer people to specialist services. This will reduce the chance of death or complications for people at risk of acute kidney injury.
Evidence-based recommendations on endobronchial valve insertion to reduce lung volume in emphysema
Summary of the evidence on tiotropium/olodaterol (Spiolto Respimat) for treating chronic obstructive pulmonary disease (COPD)..
Find out more about quality standards advisory committee 3 members at NICE.
This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines.
Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart
This guideline covers identifying, treating and managing depression in people aged 18 and over who also have a chronic physical health problem such as cancer, heart disease or diabetes. It aims to improve the care of people with a long-term physical health problem, which can cause or exacerbate depression. This has the potential to increase their quality of life and life expectancy.
Evidence-based recommendations on dronedarone (Multaq) for treating non-permanent atrial fibrillation (AF)